Overview

Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin

Status:
Completed
Trial end date:
2019-02-18
Target enrollment:
Participant gender:
Summary
Study to determine the potential pharmacokinetic interaction of candesartan cilexetil, atorvastatin as atorvastatin calcium trihydrate and amlodipine as amlodipine besilate at steady state after a multiple oral administration and to monitor the safety of the co-administration of these drugs. This study aims to determine if the steady state study pharmacokinetic parameters of any of the given drugs and the tolerability is altered when administered concomitantly.
Phase:
Phase 1
Details
Lead Sponsor:
Midas Pharma GmbH
Treatments:
Amlodipine
Atorvastatin
Candesartan